| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 09/02/2004 | CA2515887A1 Semi-solid immediate-release oral formulations comprising an anticancer hydrophobic agent, a polyglycolised glyceride and a hydrophilic carrier |
| 09/02/2004 | CA2515779A1 Contraceptive method and compositions related to proteasomal interference |
| 09/02/2004 | CA2515520A1 Methode of manufacturing glimepiride and the respective intermediate |
| 09/02/2004 | CA2515033A1 Clk-peptide and slk-peptide |
| 09/02/2004 | CA2514892A1 Compositions comprising a defined polysaccharide component |
| 09/02/2004 | CA2514889A1 Compositions comprising a polysaccharide component and one or more coating layers |
| 09/02/2004 | CA2514870A1 Compositions comprising a plurality of particles or agglomerates having a defined particle size |
| 09/02/2004 | CA2514862A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/01/2004 | EP1451364A2 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
| 09/01/2004 | EP1450834A1 Allium sativum bulb absolutes and therapeutic or cosmetic uses |
| 09/01/2004 | EP1450833A2 Anti-hsv agent for inhibiting replication of hsv-1 and hsv-2 and method of producing a substance having anti-hsv activity |
| 09/01/2004 | EP1292594B1 Quinazoline derivatives for the treatment of tumours |
| 09/01/2004 | EP1284596A4 APPARATUS AND PROCESS FOR i IN SITU /i MANUFACTURE OF ESSENCE FROM LIVING, UNCUT PLANTS |
| 09/01/2004 | EP1165528B1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 08/31/2004 | US6784254 Preventing reabsorption of bile acids from the intestine, decreasing lipoprotein cholesterol in the bloodstream, by oral administrating a sequester agent, crosslinked polyallylamine; better taste |
| 08/31/2004 | US6784198 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/26/2004 | WO2004071469A2 Methods of administering a dermatological agent to a subject |
| 08/26/2004 | WO2004071468A2 Short immunomodulatory oligonucleotides |
| 08/26/2004 | WO2004071467A2 Production of very long chain polyunsaturated fatty acids in oilseed plants |
| 08/26/2004 | WO2004071465A2 Methods and kits for use in the diagnosis and treatment of endotoxemia |
| 08/26/2004 | WO2004071464A2 Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells |
| 08/26/2004 | WO2004071463A2 Fluoromethotrexates and uses therefor |
| 08/26/2004 | WO2004071462A2 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 08/26/2004 | WO2004071461A2 Tra16 a tr4/tr2 repressor |
| 08/26/2004 | WO2004071460A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/26/2004 | WO2004071458A2 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS |
| 08/26/2004 | WO2004071457A2 Improved heat shock protein-based vaccines and immunotherapies |
| 08/26/2004 | WO2004071455A2 In vitro prediction of sunscreen pfa values |
| 08/26/2004 | WO2004071452A2 Random and non-random alkylene oxide polymer alloy compositions |
| 08/26/2004 | WO2004071451A2 Random alkylene oxide copolymers for medical and surgical utilities |
| 08/26/2004 | WO2004071449A2 Lactams as modulators of chemokine receptor activity |
| 08/26/2004 | WO2004071447A2 Substituted azole derivatives as therapeutic agents |
| 08/26/2004 | WO2004071446A2 Immune complexes |
| 08/26/2004 | WO2004071443A2 Methods and compositions for modulating stem cells |
| 08/26/2004 | WO2004071442A2 Novel bicyclic compounds and compositions |
| 08/26/2004 | WO2004071441A2 Compositions and methods to modulate immune and inflammatory responses |
| 08/26/2004 | WO2004071440A2 Thiazolyl-based compounds useful as kinase inhibitors |
| 08/26/2004 | WO2004071439A2 Immunoglobulin formulation and method of preparation thereof |
| 08/26/2004 | WO2004071438A2 Cosmetic compositions containing phenyl silicones |
| 08/26/2004 | WO2004071437A2 Compositions for enhancing sexual responsiveness |
| 08/26/2004 | WO2004071436A2 The use of gcc ligands |
| 08/26/2004 | WO2004071435A2 Enhanced Bioavailability Using Laser Resonant Homogenization |
| 08/26/2004 | WO2004071433A2 Methods of treating disease |
| 08/26/2004 | WO2004071431A2 Method and composition for treating neurodegenerative disorders |
| 08/26/2004 | WO2004071430A2 RNAi TARGETING OF VIRUSES |
| 08/26/2004 | WO2004071429A2 Lung inflammation treatment |
| 08/26/2004 | WO2004071427A2 Screening and treatment methods for prevention of preterm delivery |
| 08/26/2004 | WO2004071426A2 Compounds for the treatment of viral infection |
| 08/26/2004 | WO2004071425A2 The combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions |
| 08/26/2004 | WO2004071424A2 Immediate release formulation of n-(2-propylpentanoyl)glycinamide |
| 08/26/2004 | WO2004071423A2 Methods of administering opioid antagonists and compositions thereof |
| 08/26/2004 | WO2004071420A2 Compositions and methods for less immunogenic protein formulations |
| 08/26/2004 | WO2004071419A2 Methods and compositions for modulating glutamate transport activity in the nervous system |
| 08/26/2004 | WO2004071417A2 Inhibitors of candida albicans |
| 08/26/2004 | WO2004071416A2 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 08/26/2004 | WO2004071414A2 Therapeutic anti-hcv (al9) compounds |
| 08/26/2004 | WO2004071413A2 Method and composition for potentiating an opiate analgesic |
| 08/26/2004 | WO2004071411A2 Methods and compositions in treating pain and painful disorders using 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620 |
| 08/26/2004 | WO2004071408A2 Aβ BINDING MOLECULES |
| 08/26/2004 | WO2004071407A2 Antisense modulation of ptp1b expression |
| 08/26/2004 | WO2004071405A2 Lactate dehydrogenase: a target and reagent for diabetes therapy |
| 08/26/2004 | WO2004071403A2 Coated particles and pharmaceutical dosage forms |
| 08/26/2004 | WO2004071401A2 Hydroxamic acid derivatives as histone deacetylase inhibitors (hdca) |
| 08/26/2004 | WO2004071400A2 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity |
| 08/26/2004 | WO2004071399A2 Modulation of atp production or content in the hypothalamus |
| 08/26/2004 | WO2004071398A2 Pharmaceutical patch |
| 08/26/2004 | WO2004071395A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor ox1r (ox1r) |
| 08/26/2004 | WO2004071391A2 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| 08/26/2004 | WO2004071388A2 Medicinal compounds |
| 08/26/2004 | WO2004071387A2 Hsp60 from arthrobacter |
| 08/26/2004 | WO2004071386A2 Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use |
| 08/26/2004 | WO2004071385A2 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention |
| 08/26/2004 | WO2004071384A2 New pharmaceutical compositions based on anticholinergics and tace-inhibitors |
| 08/26/2004 | WO2004071382A2 Substituted heterocycles |
| 08/26/2004 | WO2004071376A2 Oral care composition comprising an antimicrobial agent |
| 08/26/2004 | WO2004050897A3 Methods for preparing antigen masked red blood cells having reduced hemolysis by sera |
| 08/26/2004 | WO2004047748A3 Water soluble compositions derived from plant material and preparation thereof |
| 08/26/2004 | WO2004047723A3 Method for producing fine highly porous silicium dioxide |
| 08/26/2004 | WO2004045509A3 Method of using a cox-2 inhibitor and a 5-ht1a receptor modulator as a combination therapy |
| 08/26/2004 | WO2004043354A3 Ophthalmic compositions for treating ocular hypertension |
| 08/26/2004 | WO2004035002A3 Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| 08/26/2004 | WO2004031356A3 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 08/26/2004 | WO2004017922B1 Keto cannabinoids with therapeutic indications |
| 08/26/2004 | WO2004014298B1 Composition and method for lowering cholesterol |
| 08/26/2004 | WO2004006831A3 Method and device for inducing biological processes by micro-organs |
| 08/26/2004 | WO2001051003A3 Use of lipid conjugates in the treatment of disease |
| 08/26/2004 | US20040167207 Synergistic mixture of vitamin k and warfarin |
| 08/26/2004 | US20040167203 Absorption enhancing agents |
| 08/26/2004 | US20040167196 Treatment of benign prostatic hyperplasia |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040166184 Plant extract; cognition activators |
| 08/26/2004 | US20040166182 Synergistic mixture; enzyme inhibitors; side effect reduction of gastrointestinal disorders |
| 08/26/2004 | US20040166181 Mixture of soybean protein and chromium |
| 08/26/2004 | US20040166162 Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
| 08/26/2004 | US20040166160 Modulate release of cyclobenzaprine; multilayer tablet containing hydrated form of cyclobenzaprine; controlling concentration in blood |
| 08/26/2004 | US20040166159 Brain diosrders; controlling dopamine concentration |
| 08/26/2004 | US20040166099 Molecules preferentially associated with effector T cells and methods of their use |
| 08/26/2004 | US20040166058 Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 08/26/2004 | DE10306179A1 Composition useful for preventing stroke comprises dipyridamole or its salt, acetyl salicylic acid and an angiotensin II antagonist |
| 08/26/2004 | CA2520591A1 Improved heat shock protein-based vaccines and immunotherapies |